Veterinary Medicine Information website

MIXOHIPRA-H LIOFILIZADO Y DISOLVENTE PARA SUSPENSION INYECTABLE PARA CONEJOS

Authorised
  • Myxoma virus, strain VMI 30, Live

Product identification

Medicine name:
MIXOHIPRA-H LIOFILIZADO Y DISOLVENTE PARA SUSPENSION INYECTABLE PARA CONEJOS
Active substance:
  • Myxoma virus, strain VMI 30, Live
Target species:
  • Rabbit
Route of administration:
  • Intradermal use
  • Subcutaneous use

Product details

Active substance and strength:
  • Myxoma virus, strain VMI 30, Live
    3.00
    50% cell culture infectious dose
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intradermal use
    • Rabbit
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Rabbit
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AD02
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 2919 ESP
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 21/10/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 21/10/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 21/10/2024